Gordon Haskett analyst Robert Mollins downgrades Booking Holdings (NASDAQ:BKNG) from Buy to Hold.
Ardelyx Presents Data At DDW 2023 On IBSRELA, A First-In-Class Treatment For IBS-C In Adults
IBSRELA provides meaningful reduction of multiple abdominal symptoms
Patient-reported outcomes are strongly correlated with IBS-C abdominal symptom score
WALTHAM, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Ardelyx,